198 related articles for article (PubMed ID: 5477536)
21. [Rubella in São Paulo. Serological surveys in 349 subjects. Clinico-serological evaluation of 2 types of attenuated virus vaccine].
Veronesi R; Moura RA; Penna HA; Strauss A; Zuccas WA; Issler H
Rev Hosp Clin Fac Med Sao Paulo; 1971 Apr; 26(2):65-8. PubMed ID: 5104431
[No Abstract] [Full Text] [Related]
22. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
Fara GM; Galli MG; Nodari R; Saccani CF; Marangoni L; Bozzetti A; Tarantino F
Minerva Med; 1970 Apr; 61(30 Suppl):1574-7. PubMed ID: 5439721
[No Abstract] [Full Text] [Related]
23. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
[No Abstract] [Full Text] [Related]
24. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
Grant L; Belle EA; Provan G; King SD; Sigel MM
J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
[TBL] [Abstract][Full Text] [Related]
25. The effects of Cendehill rubella vaccine in children under unusually complicated circumstances.
Chang TW; Dickinson PC; Weinstein L
J Infect Dis; 1969 Aug; 120(2):237-41. PubMed ID: 4980602
[No Abstract] [Full Text] [Related]
26. A controlled family study of live, attenuated rubella-virus vaccine.
Lefkowitz LB; Rafajko RR; Federspiel CF; Quinn RW
N Engl J Med; 1970 Jul; 283(5):229-32. PubMed ID: 4912790
[No Abstract] [Full Text] [Related]
27. [Characteristics of the reactogenic properties and effectiveness of live rubella vaccine].
Iakovleva NV; Nasibov MN; Smorodintsev AA
Vopr Virusol; 1969; 14(3):365-9. PubMed ID: 5820958
[No Abstract] [Full Text] [Related]
28. Rubella immunization.
Carver DH; Drachman RH; Neff JM; Seto DS
Johns Hopkins Med J; 1970 Feb; 126(2):119-20. PubMed ID: 5439129
[No Abstract] [Full Text] [Related]
29. [Vaccination of young women against rubella, mainly in the post-partum period].
Zourbas J; Toulouse R; Colombani J; Esmieu F; Buil M; Hamonou M
Rev Fr Gynecol Obstet; 1970 Mar; 65(3):107-13. PubMed ID: 5442694
[No Abstract] [Full Text] [Related]
30. Studies on live rubella vaccine. 3. Field trials with vaccines attenuated by serial passages in primary pig kidney cells.
Suzuki M; Minekawa Y; Osame J; Ueda S; Ogino T
Biken J; 1973 Dec; 16(4):149-54. PubMed ID: 4799206
[No Abstract] [Full Text] [Related]
31. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
Naficy K; Nategh R; Ahangary S; Mohsenin H
Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
[No Abstract] [Full Text] [Related]
32. [Anti-rubella vaccination (Cendehill 51 strain). Preliminary results].
Nameche J; Dachy A; Thiry L
Acta Clin Belg; 1968; 23(2):97-102. PubMed ID: 5746771
[No Abstract] [Full Text] [Related]
33. Study on rubella immunization in Thailand. 2. Clinical observations on vaccinated children with Cendehill strain.
Thongcharoen P; Bukkavesa S; Habanananda S; Jaiwatana S; Chearskul S; Oonsombat P; Charoenrath M; Wasi C; Panpatana P; Sarasombath S
J Med Assoc Thai; 1974 Sep; 57(9):439-41. PubMed ID: 4425433
[No Abstract] [Full Text] [Related]
34. Evaluation of attenuated rubella virus vaccine in families.
Mogabqab WJ; Stowe FR
Am J Dis Child; 1971 Aug; 122(2):122-8. PubMed ID: 5564155
[No Abstract] [Full Text] [Related]
35. [Clinico-serological evaluation of a vaccine against rubella].
Figueroa M; Núñez D
Bol Oficina Sanit Panam; 1972 Mar; 72(3):244-9. PubMed ID: 4258829
[No Abstract] [Full Text] [Related]
36. [Practical use of an attenuated live anti-rubella vaccine (Cendehill 5) in childhood].
Rondinini B; Beccari A
Clin Pediatr (Bologna); 1969 Oct; 51(10):522-9. PubMed ID: 5406102
[No Abstract] [Full Text] [Related]
37. [Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine].
Grasso A; Gagnoni G; Cantagalli P; Dianzani F; Piazzi SE
G Mal Infett Parassit; 1969 Jul; 21(7):603-15. PubMed ID: 5364953
[No Abstract] [Full Text] [Related]
38. [Evaluation of rubella vaccine (HPV 77, DK 12) in Mexico City. Possible transmission of its viral strain].
Ruíz-Gomez J; Gutiérrez G; Velasco-Cándano LR
Arch Invest Med (Mex); 1971; 2(2):95-102. PubMed ID: 5136438
[No Abstract] [Full Text] [Related]
39. [Clinical test of an anti-rubella vaccine on a group of children belonging to a closed community].
Gasparini V; Trivello R; Diana L; Romano M; Drago E; Rausa G
Minerva Med; 1970 Apr; 61(30 Suppl):1583-9. PubMed ID: 5439723
[No Abstract] [Full Text] [Related]
40. Immunization of man against rubella. Discussion on sessions 3 and IV.
Am J Dis Child; 1969 Aug; 118(2):307-21. PubMed ID: 4978511
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
